Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,648 public trials 303 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal

NCT03367130

Conditions: Antiretroviral Therapy, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Seti Zonal Hospital Dhangadi, State 7., Nepal

View Trial Details

Completed

Safer Conception Intervention for HIV-1 Serodiscordant Couples

NCT03030768

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: University of Washington, Coordinating Center Seattle, Washington, United States

Partners in Health, Research and Development Thika, Kenya

View Trial Details

Completed

Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults

NCT01811823

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +23 more
Locations: Respiratory and Meningeal Pathogens research unit Johannesburg, Gauteng, South Africa

View Trial Details

Completed

The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)

NCT02473367

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

NCT02165202

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: New Jersey Medical School Clinical Research Center Newark, New Jersey, United States

Bronx Prevention Center The Bronx, New York, United States

Emavundleni Clinical Research Site Cape Town, South Africa

Spilhaus Clinical Research Site Belgravia, Harare, Zimbabwe

View Trial Details

Completed

A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)

NCT01930045

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Causes of Rotavirus Vaccine Failure in Zambian Children

NCT01886833

Conditions: Blood-Borne Infections, Communicable Diseases, Diarrhea, +17 more
Locations: Centre for Infectious Disease Research in Zambia Lusaka, Zambia

View Trial Details

Completed

3BNC117 and 10-1074 in HIV-infected Individuals

NCT02825797

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: The Rockefeller University New York, United States

University Hospital of Cologne Cologne, Germany

View Trial Details

Completed

A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)

NCT01717287

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Engagement to Care South Africa

NCT02417233

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: Moses Kotane Sub-district clinics Mabeskraal, Northwest, South Africa

Rustenburg Sub-district clinics Rustenburg, Northwest, South Africa

View Trial Details

Lentivirus Infections

Lentivirus Infections trial results

Related conditions